Results 51 to 60 of about 736,333 (253)

No evidence that gaze anxiety predicts gaze avoidance behavior during face-to-face social interaction

Scientific Reports, 2022
Eye contact is an indispensable social signal, yet for some individuals it is also a source of discomfort they fear and avoid. However, it is still unknown whether gaze anxiety actually produces avoidant gaze behavior in naturalistic, face-to-face ...
Daniel Tönsing, Bastian Schiller, Antonia Vehlen, Ines Spenthof, Gregor Domes, Markus Heinrichs   +5 more
doaj   +1 more source

Rational Use of Herbal Products in Pediatric Patients Treated With Anticancer Drugs in the European Union

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Introduction The use of herbal medical preparation (HMP) is rising among pediatric oncology patients, often to manage treatment‐related symptoms. Their effectiveness remains uncertain, and the risk of herb–drug interactions is underestimated.
Orianne Mahot, Mathieu Corvaisier, Laurence Spiesser‐Robelet, Mylène Duplan, Isabelle Pellier, Delphine Bourneau‐Martin, Séverine Derbré   +6 more
wiley   +1 more source

Into the Unknown Unknowns: Engaged Human Learning through Participation in Language Model Agent Conversations

Proceedings of the 2024 Conference on Empirical Methods in Natural Language Processing
While language model (LM)-powered chatbots and generative search engines excel at answering concrete queries, discovering information in the terrain of unknown unknowns remains challenging for users. To emulate the common educational scenario where children/students learn by listening to and participating in conversations of their parents/teachers, we ...
Yucheng Jiang, Yijia Shao, Dekun Ma, Sina J. Semnani, Monica S. Lam   +4 more
openaire   +2 more sources

Psychosocial Functioning After Pediatric Bone Sarcoma: Generic and Survivor‐Specific Outcomes in Adolescent and Young Adult Patients

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Pediatric bone sarcoma patients and survivors may experience psychosocial challenges related to childhood cancer after their intensive, body‐altering treatment. This cross‐sectional study aimed to evaluate generic and survivor‐specific psychosocial outcomes in a national cohort of pediatric bone sarcoma patients and survivors, and ...
Hinke van der Hoek, Heleen Maurice‐Stam, Laura R. Beek, Jennifer van Dijk, Marjolein E. M. Langemeijer, Relinde W. Slooff‐Lentink, Alied M. van der Aa‐van Delden, Anne Westerweel, Marloes van Gorp, Hendrik W. B. Schreuder, Lianne M. Haveman, W. Peter Bekkering, Leonie G. Tigelaar, Johannes H. M. Merks, Martha A. Grootenhuis   +14 more
wiley   +1 more source

Differences in pain, bleeding, and satisfaction during medical abortion at very early gestations

Acta Obstetricia et Gynecologica Scandinavica
Introduction Little is known regarding the impact of gestation on pain, bleeding duration, and satisfaction in early medical abortion (termination of pregnancy).
Frida Gyllenberg, Karin Brandell, Tagrid Jar‐Allah, Helena Kopp Kallner, John Reynolds‐Wright, Clare Boerma, Sharon Cameron, Helena Hognert, Oskari Heikinheimo, Janina Kaislasuo, Kristina Gemzell‐Danielsson   +10 more
doaj   +1 more source

Guessing Meaning From Word Sounds of Unfamiliar Languages: A Cross-Cultural Sound Symbolism Study

Frontiers in Psychology, 2019
Sound symbolism refers to a non-arbitrary relationship between the sound of a word and its meaning. With the aim to better investigate this relationship by using natural languages, in the present cross-linguistic study 215 Italian and Polish participants
Anita D’Anselmo, Giulia Prete, Przemysław Zdybek, Luca Tommasi, Alfredo Brancucci   +4 more
doaj   +1 more source

Re‐Irradiation in Pediatric Diffuse Midline Glioma: A Multi‐Institutional Retrospective Study

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Children with recurrent diffuse midline gliomas (DMGs) have limited therapeutic options at recurrence. Re‐irradiation (RT2) may be used at progression, but with uncertainty about the benefit. Methods We conducted a multi‐institutional retrospective study of children aged < 18 with DMG treated at three centers (Toronto, Canada ...
Ajay Thomas Alex, Sean P. Hassan, Helen Benghiat, Liam Herbert, Jennifer Adamski, Shivani Bailey, Claire Esler, Louise Brookes, Molly Bamber, Grace Koudou, Karen Waite, Julie Bennett, Anirban Das, Derek S. Tsang   +13 more
wiley   +1 more source

Estimating Unknown English Words From User Smartphone Reading Behaviors

IEEE Access
Vocabulary learning is essential for language study, and it is crucial to identify unknown words for users. Conventional English vocabulary learning methods specify words to be learned based on the frequency of vocabulary use and cannot suggest unknown ...
Riku Higashimura, Ko Watanabe, Andrew Vargo, Motoi Iwata, Andreas Dengel, Koichi Kise   +5 more
doaj   +1 more source

Association Between Dinutuximab Beta Exposure and Post‐End‐of‐Treatment Survival in Neuroblastoma: A Weighted Patient‐Level Analysis of Three Clinical Studies

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Objectives The association between exposure to dinutuximab beta (DB) and event‐free survival (EFS) or overall survival (OS) of neuroblastoma patients was assessed using data collected during three clinical trials (five cohorts). Methods A systematic review (March 2026) was conducted to identify relevant studies (prospective; registered DB ...
Przemysław Holko, Holger N. Lode, Alberto Garaventa, Carla Manzitti, Roberto Luksch, Dominique Valteau‐Couanet, Marion Gambart, John Anderson, Juliet Gray, Adela Canete, Lucas Moreno, Aleksandra Wieczorek, Cormac Owens, Shifra Ash, Isaac Yaniv, Genevieve Laureys, Hans Loibner, Katarzyna Śladowska, Ruth Ladenstein, Paweł Kawalec   +19 more
wiley   +1 more source

Long‐Term Outcomes of Patients With Relapsed/Refractory Neuroblastoma Treated on ANBL1221: A Report From the Children's Oncology Group

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Results of COG ANBL1221 changed treatment paradigms for patients with relapsed/refractory neuroblastoma. Chemoimmunotherapy with irinotecan/temozolomide/dinutuximab is now used as both bridge therapy following suboptimal response to induction and as treatment in first relapse.
Elizabeth Sokol, Arlene Naranjo, Lulu Chen, Rajen Mody, Steven G. DuBois, Rochelle Bagatell, Navin Pinto   +6 more
wiley   +1 more source